Elicio Therapeutics Inc. (ELTX)
NASDAQ · Healthcare
Elicio Therapeutics Inc. Revenue 2020–2022
Elicio Therapeutics Inc. annual/quarterly revenue history and growth rate from 2020 to 2023. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Elicio Therapeutics Inc. revenue for the quarter ending March 31, 2023 was 0, a 100.00% decrease year-over-year.
- Elicio Therapeutics Inc. revenue for the twelve months ending March 31, 2023 was 2.3 M, a 28.05% decrease year-over-year.
- Elicio Therapeutics Inc. annual revenue for 2022 was 2.3 M, a 91.87% decrease from 2021.
- Elicio Therapeutics Inc. annual revenue for 2021 was 28.3 M, a 883.06% increase from 2020.
- Elicio Therapeutics Inc. annual revenue for 2020 was 2.9 M.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Elicio Therapeutics Inc. Revenue — FAQ
Elicio Therapeutics Inc. (ELTX) revenue over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
What is Elicio Therapeutics Inc.'s revenue?
Elicio Therapeutics Inc. (ELTX) reported revenue of $2M for fiscal 2022.
Where can I see ELTX's revenue history?
The chart and table above show Elicio Therapeutics Inc.'s revenue by year and by quarter, including the growth rate.